COVID-19: learning from lessons to guide treatment and prevention interventions

CR Triggle, D Bansal, EABA Farag, H Ding, AA Sultan - MSphere, 2020 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and first emerged in …

An overview on the treatments and prevention against COVID-19

Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …

COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

R Chakraborty, S Parvez - Biochemical pharmacology, 2020 - Elsevier
COVID-19, the greatest public health emergency of the 21st century, has affected 215
countries and territories around the world resulting in 15,151,738 confirmed cases and …

[PDF][PDF] COVID-19 Treatment: The Race Against Time. Electron J Gen Med. 2020; 17 (6): em227

M Aljofan, A Gaipov - 2020, 2020 - ejgm.co.uk
The new outbreak of the novel coronavirus infection emerged in Wuhan-China in late 2019,
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …

Coronavirus disease (COVID-19): Current status and prospects for drug and vaccine development

K Ita - Archives of medical research, 2021 - Elsevier
The Coronavirus disease 2019 (COVID-19) pandemic has spread to almost all nooks and
corners of the world. There are numerous potential approaches to pharmacologically fight …

COVID-19: A review of therapeutic strategies and vaccine candidates

V Izda, MA Jeffries, AH Sawalha - Clinical Immunology, 2021 - Elsevier
The world is engulfed by one of the most widespread and significant public health crises in
decades as COVID-19 has become among the leading causes of death internationally. The …

Racing to immunity: journey to a COVID‐19 vaccine and lessons for the future

E Calvo Fernández, LY Zhu - British journal of clinical …, 2021 - Wiley Online Library
SARS‐CoV‐2 is the novel coronavirus behind the COVID‐19 pandemic. Since its
emergence, the global scientific community has mobilized to study this virus, and an …

[HTML][HTML] The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution

RM Burgos, ME Badowski, E Drwiega… - Drugs in …, 2021 - ncbi.nlm.nih.gov
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …

Current insight into the novel coronavirus disease 2019 (COVID-19)

SK Saxena, S Kumar, VK Maurya, R Sharma… - … Disease 2019 (COVID …, 2020 - Springer
SARS-CoV-2 is a novel strain of coronavirus that has not been previously identified in
humans. It has been declared a pandemic and has infected at least 1,844,683 individuals …

[PDF][PDF] Therapeutics and COVID-19: living guideline, 13 January 2023

World Health Organization - 2023 - apps.who.int
As of December 2022, there have been over 642 million confirmed cases of COVID-19 (10).
The pandemic has thus far claimed approximately 6.62 million lives (10). Vaccination is …